RUBICON RESEARCH LIMITED (RUBICON): Rubicon Research Share Price rises 3.05% as stock trades at Rs 1,817.50
- September 17, 2026
- Posted by: Harsh Piplani
- Category: News
Rubicon Research Share Price moved higher today, with RUBICON closing at Rs 1,817.50 after a 3.05% gain from the previous close of Rs 1,763.75. The company’s market capitalisation stands at Rs 30,049.01 Cr, which places this Stock News update firmly in the higher-valuation part of the healthcare universe. Today’s open was Rs 1,757.55, the day low was Rs 1,757.55 and the day high was Rs 1,817.50, showing that the session finished at its highest recorded level for the day. The verified data confirms the price event, while no company-specific catalyst is established by the supplied information. For readers tracking Rubicon Research Share Price Today, the main focus is the size of the move, the premium valuation metrics and how the stock compares with healthcare peers on Univest.
In broader market terms, Rubicon Research Share Price Today is being discussed as a share price rise rather than a narrative-led rerating. Univest data shows turnover of Rs 0.52 Cr, which is a factual traded-value metric and should be read alongside the price move rather than as a behavioural signal. For investors scanning Stocks in News, this is a clean same-day update on RUBICON Share Price, supported by exact price data, market cap and financial ratios. The key question for Rubicon Research Stock News is not why the stock moved in a speculative sense, but what the verified numbers say about valuation, profitability and peer context.
Rubicon Research Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,817.5 |
| Previous Close | Rs 1,763.75 |
| Today's Move | Rs 53.75 (+3.05%) |
| Open | Rs 1,757.55 |
| High | Rs 1,817.5 |
| Low | Rs 1,757.55 |
| Turnover | Rs 0.52 crore |
| Market Capitalisation | Rs 30,049.01 crore |
| Market Cap Category | Large Cap |
RUBICON RESEARCH LIMITED (RUBICON) rose to Rs 1,817.5 from the previous close of Rs 1,763.75, a move of Rs 53.75 or 3.05%. The stock opened at Rs 1,757.55, reached a high of Rs 1,817.5, recorded a low of Rs 1,757.55.
Rubicon Research Share Price Today rose Rs 53.75 from the previous close, or 3.05%, to finish at Rs 1,817.50. The stock opened at Rs 1,757.55, traded between Rs 1,757.55 and Rs 1,817.50, and ended at the day high. This is the complete same-day price action confirmed by the supplied data. No company-specific catalyst is established by the data, so the event should be read as a verified price rise in RUBICON Stock News rather than as an explained event.
RUBICON RESEARCH LIMITED (RUBICON) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 30,049.01 crore |
| P/E Ratio | 101.3x |
| P/B Ratio | 21.75x |
| ROE | 27.84% |
| ROCE | 29.22% |
| EPS | Rs 17.41 |
| Book Value Per Share | Rs 81.09 |
| Dividend Yield | 0.09% |
RUBICON RESEARCH LIMITED (RUBICON) fundamental metrics show P/E 101.3x, P/B 21.75x, ROE 27.84%, ROCE 29.22%. These figures provide context only and are not a buy or sell signal.
RUBICON RESEARCH LIMITED has a market capitalisation of Rs 30049.01 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 101.3x, P/B at 21.75x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 27.84% and ROCE of 29.22%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 17.41, book value per share of Rs 81.09, dividend yield of 0.09%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 31.35x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 101.3x |
| Benchmark Median P/E | 31.35x |
| Benchmark Average P/E | 47.81x |
| Benchmark P/E Range | 3.45x to 661.74x |
| Company P/B Ratio | 21.75x |
| Benchmark Median P/B | 2.98x |
| Company ROE | 27.84% |
| Benchmark Median ROE | 11.78% |
| Company ROCE | 29.22% |
| Benchmark Median ROCE | 13.65% |
| Company Market Capitalisation | Rs 30,049.01 crore |
| Benchmark Median Market Cap | Rs 735.67 crore |
RUBICON RESEARCH LIMITED (RUBICON) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
RUBICON RESEARCH LIMITED (RUBICON) has a P/E ratio of 101.3x, which is above the benchmark median of 31.35x, a difference of +223.13%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
RUBICON RESEARCH LIMITED (RUBICON) has a ROE of 27.84%, which is above the benchmark median of 11.78%, a difference of +136.33%. RUBICON RESEARCH LIMITED (RUBICON) has a ROCE of 29.22%, which is above the benchmark median of 13.65%, a difference of +114.07%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,40,277.97 | 36.77 | 5.14 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,43,965.63 | 83.5 | 13.83 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,84,478.41 | 84.11 | 20.44 | 26.76 | 19.27 |
| Cipla Ltd. | CIPLA | 1,09,949.53 | 32.59 | 3.12 | 11.83 | 16 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,09,625.67 | 24.42 | 4.09 | 19.69 | 21.39 |
RUBICON RESEARCH LIMITED (RUBICON) has a P/E ratio of 101.3x compared with the displayed peer median of 36.77x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 27.84% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 29.22% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. RUBICON RESEARCH LIMITED (RUBICON) has a market capitalisation of Rs 30,049.01 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Rubicon Research
- Rubicon Research Share Price rose 3.05% today to Rs 1,817.50.
- The day high of Rs 1,817.50 matched the closing price.
- Market capitalisation stands at Rs 30,049.01 Cr.
- P/E is 101.3 and P/B is 21.75, both above the same-industry benchmark medians.
- ROE is 27.84 and ROCE is 29.22, both above the industry medians in the supplied benchmark set.
About Rubicon Research
Rubicon Research Limited operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied data does not break out revenue segments, product mix or geographic mix, so the company should be understood through the financial and sector labels available here. Its current market capitalisation of Rs 30,049.01 Cr places it well above the median company size in the same-industry benchmark set.
For readers following Rubicon Research Share Price and Rubicon Research Company News, the business profile matters because the stock is being valued on a rich earnings and book-value multiple while also posting strong return ratios. The current Rubicon Research Share Price therefore sits at the intersection of a healthcare industry label, premium valuation and above-benchmark profitability. Univest presents this information as a factual stock update, not as a forecast, so investors can review the company alongside other healthcare names in one place.
Track Rubicon Research Share Price on Univest
Use RUBICON RESEARCH LIMITED (RUBICON) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
You can track Rubicon Research Share Price Live on Univest for current price updates, fundamental ratios, shareholding pattern, 52-week levels and market insights. Univest also brings together Rubicon Research Stock Analysis, Rubicon Research Share Price Update and Rubicon Research Latest News in one place, making it easier to compare the stock with peers and sector benchmarks.
For investors searching Rubicon Research Share Price Today, Univest provides a structured view of market cap, valuation, earnings ratios and company context. That makes it useful for anyone who wants a single reference point for RUBICON NSE and RUBICON BSE tracking, alongside broader stock updates from the Indian stock market.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why is Rubicon Research Share Price rising today?
Ans. The verified data shows Rubicon Research Share Price rose 3.05% to Rs 1,817.50. The supplied information confirms the price event, but it does not establish a company-specific catalyst for the move.
What is Rubicon Research Share Price today?
Ans. Rubicon Research Share Price today is Rs 1,817.50. The stock gained Rs 53.75 from the previous close of Rs 1,763.75 and finished the session at its day high. The previous close was Rs 1,763.75.
What does Rubicon Research’s market cap show?
Ans. Rubicon Research has a market capitalisation of Rs 30,049.01 Cr. That is well above the same-industry benchmark median of Rs 735.67 Cr and also above the benchmark average of Rs 13,941.93 Cr.
How does Rubicon Research compare on valuation?
Ans. Rubicon Research trades at a P/E of 101.3 and a P/B of 21.75. Both are above the healthcare industry medians of 31.35 and 2.98, indicating a premium valuation in the supplied dataset.
How strong are Rubicon Research’s profitability ratios?
Ans. Rubicon Research reports ROE of 27.84 and ROCE of 29.22. Both are above the benchmark medians of 11.78 and 13.65, which places the company above the industry middle on these return measures.
What do EPS, book value and dividend yield show for Rubicon Research?
Ans. EPS is Rs 17.41, book value is Rs 81.09 and dividend yield is 0.09. These three figures help explain earnings per share, accounting net worth and the historical payout relationship to the current price.
